Propanc Biopharma, Inc.
Filed Feb 2, 2026.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Feb 2, 2026
Contents
Experts
The financial statements of Propanc Biopharma as of June 30, 2025 and 2024, appearing in this prospectus and registration statement of which this prospectus forms a part, have been audited by Salberg & Company, P.A., independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report, given on the authority of such firm as experts in accounting and auditing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.